Micron Biomedical today announced the grand opening of its world-class manufacturing facility spanning more than 26,000 ...
Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
Oxford Gene Technology (OGT) has launched its microarray product, an Escherichia coli K12 Chromatin Immunoprecipitation (ChIP) on chip. OGT Chip 2 microarrays can be used to identify the binding ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...